This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
 
What to Watch on Wall Street for Tuesday, September 30th

Here's "What to Watch on Wall Street" for Tuesday, September 30th.

BMW Launches Automated Driving Project in China with Baidu

BMW is testing out self-driving cars in China.

Cintas Beats Q1 Street Estimates, Offers Bullish Outlook

Cintas posted first quarter earnings of $0.93 a share on revenue of $1.10 billion.

Yahoo's Marissa Mayer to Review Starboard's Proposed AOL Bid

The pressure is on Yahoo CEO Marissa Mayer to explore a tie-up with AOL.

State Attorneys General to Probe Antitrust Issues on Dollar General Bid

Certain state attorneys general are investigating Dollar General's bid for Family Dollar over antitrust concerns.

Real Money Previews

Jim Cramer on the Stock Market: What Nike Is Telling Us

Maybe its stellar result shows things aren't that bad.

Top 10 Reasons for Being Cautious; An Oldie But Goodie: Best of Kass

In highlights from his trading diary of the past week, Doug Kass writes about caution in the market and words of wisdom from 'Fast Times at Ridgemont High.'

Market Stuck in Weird Mode; Fed Is in Another World: Jim Cramer's Best Blogs

Catch up on Jim Cramer's thinking over the last week about how investors can make or lose everything in a single session and the world's effect on the Fed.

Mad Money Recap

'Mad Money' Lightning Round: I'm Not Very Happy With Oracle

Cramer is no fan of Annaly Capital but does like Opko Health and Dow Chemical.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

Forget the Top Talk -- QE5 Is Coming, and Here's How to Profit

The Fed is ready to step in and dump cash into the system again. Here's why -- and how to take advantage with your portfolio.

5 Hated Earnings Stocks You Should Love

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

5 Rocket Stocks to Buy to Avoid the Selloff

These stocks have short-term gain catalysts and longer-term growth potential.

3 Unusual-Volume Biotech Stocks in Breakout Territory

Keep these biotech stocks rising on unusual volume on your breakout trading radar.

3 Big Stocks With Big Volume to Trade for Big Breakouts

These stocks rising on unusual volume are within range of triggering breakout trades.

MainStreet

What to Do When You Send an Email You Absolutely Shouldn’t Have

Did you accidentally type something in an email you wish you could take back? Here’s how to recover.

In Better Homeowner Market, 19% Still 'Under-Equitied,' Barely Above Water

Of 44 million residential properties with positive equity, approximately 9 million have less than 20% equity and 1.3 million of those have less than 5%.

We'll Spend $11.3B on Halloween, a Good Sign for Holidays, Economy

The average family will spend $125 apiece on Halloween fun, led by families but with a growing number of adults taking part.

Why You Should Always Talk to Future Neighbors When Buying a Home

Does the neighborhood have hidden problems? Are the restaurants any good? Your future neighbors may be freest to give honest answers.

Why Full-Time Working Women Earn $320,000 Less Than Men Over a Lifetime

On September 15, the Paycheck Fairness Act was again voted down for the fourth time since 2011, including just this past April. Female workers just can't catch a break.

Biotech

Clovis Shares Higher on Improved Outlook for Lung Cancer Drug

Clovis Oncology shares are higher Monday because AstraZeneca, its direct competitor to develop a new, genetically targeted lung cancer drug, slipped this weekend.

Seattle Genetics Seeks Expanded Use of Lymphoma Drug on Study Win

Adcetris delayed disease progression in Hodgkin lymphoma patients following a stem cell transplant.

Biotech Stock Mailbag: ProQR, Vertex Pharma, Tekmira, Agios

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Beyond Wall St.

Deal News

DreamWorks and SoftBank Deal Talks Reportedly Have Cooled

Deal talks between DreamWorks and SoftBank have reportedly cooled, leaving investors wondering if their hope for a blockbuster merger has now become a bust.

Yahoo's Marissa Mayer to Review Starboard's Proposed AOL Bid

The pressure is on Yahoo CEO Marissa Mayer to explore a tie-up with AOL.

McDonald's Rumor Resonates With JPMorgan Report on Trapped Value

John Ivankoe, a restaurants analyst at JPMorgan said he increasingly believes 'substantive structural change at McDonald’s may originate from outside,' rather than within the company.

TheStreetTV
Spin Space

Jim Cramer

Cramer Answers Twitter Questions on Yahoo!, Ciena, Bank of America

Jim Cramer answers viewers' Twitter questions from the floor of the New York Stock Exchange.

Herb Greenberg

Herb Greenberg: Too Soon to Question GoPro's Earnings Quality?

Keep these points from its most recent quarter in mind.

Stephanie Link

Jim Cramer Tells Stephanie Link Downtrend in Commodities an Opportunity to Buy

Recently commodities such as oil, gold and iron ore have been taking it on the chin with prices at their lowest level in five years.

Chris Ciaccia

Apple iPhone, Not Android Devices, Dominate Web Traffic

Apple's new iPhones, the iPhone 6 and iPhone 6 Plus, may continue to add to Apple's lead when it comes to traffic, as consumers use iOS more than Android devices.

Adam Feuerstein

Clovis Shares Higher on Improved Outlook for Lung Cancer Drug

Clovis Oncology shares are higher Monday because AstraZeneca, its direct competitor to develop a new, genetically targeted lung cancer drug, slipped this weekend.

Dan Freed

Mortgage REITs Offer Great Yields, but Big Risks Remain

If the market moves sideways and interest rates stay lower for longer, mortgage REITS like Annaly and AGNC may be one of the few ways to outperform the market.

Ted Reed

Airbus A320neo Takes Its First Flight, Will Fly for American in 2017

American Airlines, which operates the world's largest Airbus fleet, has orders for 100 Airbus A320neos and expects its first aircraft in 2017.

Leon Lazaroff

Protesters Try to Take Wall Street, Settle for Broadway Sit-In

Climate change protesters, thwarted in their attempt to march on Wall Street, took over lower Broadway, singing chants and sending Tweets.

Submit an article to us!
DOW 17,071.22 -41.93 -0.24%
S&P 500 1,977.80 -5.05 -0.25%
NASDAQ 4,505.8520 -6.3420 -0.14%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs